Literature DB >> 9266387

Mutation of ornithine transcarbamylase (H136R) in a girl with severe intermittent orotic aciduria but normal enzyme activity.

S Vella1, F Steiner, V Schlumbom, R Zurbrügg, U N Wiesmann, T Schaffner, B Wermuth.   

Abstract

Ornithine transcarbamylase deficiency shows X-linked inheritance with partial dominant expression in carrier females. We studied a girl with intermittent severe orotic aciduria and mild hyperammonaemia despite apparently normal enzyme activity in the liver. Sequence analysis of all 10 exons of the ornithine transcarbamylase gene revealed a novel A-->G exchange (A502G) in exon 5 which changes His-136 to arginine in the ornithine transcarbamylase protein. Km values for carbamyl phosphate and ornithine determined in the patient's liver were comparable to those of wild-type enzyme but, unlike the wild-type enzyme, the mutant enzyme was unstable upon freezing and thawing. Electron microscopy revealed several giant mitochondria with paracrystalline inclusions. The results are compatible with the assumption that the mutant enzyme cannot form a functional complex with carbamyl phosphate synthetase and the ornithine carrier, resulting in decreased availability of substrates and diminished enzyme activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266387     DOI: 10.1023/a:1005397329395

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

Review 1.  The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency.

Authors:  M Tuchman
Journal:  J Lab Clin Med       Date:  1992-12

2.  Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.

Authors:  E R Hauser; J E Finkelstein; D Valle; S W Brusilow
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

3.  X-chromosome inactivation in human liver: confirmation of X-linkage of ornithine transcarbamylase.

Authors:  F C Ricciuti; T D Gelehrter; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1976-07       Impact factor: 11.025

Review 4.  X-chromosome inactivation and developmental patterns in mammals.

Authors:  M F Lyon
Journal:  Biol Rev Camb Philos Soc       Date:  1972-01

5.  Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies.

Authors:  A M Stadhouders; P H Jap; H P Winkler; H M Eppenberger; T Wallimann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Ultrastructural, immunocytochemical and stereological investigation of hepatocytes in a patient with the mutation of the ornithine transcarbamylase gene.

Authors:  K P Zimmer; I Matsuda; T Matsuura; M Mori; J P Colombo; H D Fahimi; H G Koch; K Ullrich; E Harms
Journal:  Eur J Cell Biol       Date:  1995-05       Impact factor: 4.492

7.  Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].

Authors:  T Matsuura; R Hoshide; C Setoyama; K Shimada; Y Hase; T Yanagawa; M Kajita; I Matsuda
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

8.  Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; M Msall; A L Beaudet; J Trojak
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

9.  The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

Authors:  M Tuchman; H Morizono; O Reish; X Yuan; N M Allewell
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

10.  Ornithine transcarbamylase deficiency: new sites with increased probability of mutation.

Authors:  E O Oppliger Leibundgut; S Liechti-Gallati; J P Colombo; B Wermuth
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

View more
  2 in total

1.  Symptomatic ornithine carbamoyltransferase deficiency (point mutation H202P) with normal in vitro activity.

Authors:  M Staudt; B Wermuth; P Freisinger; A Hässler; B F Pontz
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

2.  Complex I deficiency in association with structural abnormalities of the diaphragm and brain.

Authors:  C Ellaway; K North; S Arbuckle; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.